GM Mosquito Progeny Not Dying in Brazil: Study

The biotech Oxitec had released the genetically engineered insects with the hope that they would breed with wild populations and produce offspring that die young. But that’s not always happening.

Written byKerry Grens
| 2 min read
mosquito aedes aegypti jacobina brazil oxitec genetic engineering gm genetically modified dengue zika

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Update (September 18): Scientific Reports has issued an editor’s note, stating that “the conclusions of this paper are subject to criticisms that are being considered by editors.” In a statement sent to The Scientist, Oxitec says it takes issues with a number of conclusions the authors made in their report. Among them, “The authors infer that Oxitec’s self-limiting genes persist in the environment. Yet as confirmed by their own data, multiple other scientific studies and regulatory filings, this is not the case. Oxitec’s self-limiting genes do not establish or spread in the environment.” The journal’s note states that it will issue another response once the issues are resolved.

ABOVE: © ISTOCK.COM, KWANGMOOZAA

A field experiment in Brazil that deployed genetically modified mosquitoes to control wild populations of the pest may be having unintended consequences. According to a genetic analysis of mosquitoes in the area, it appears the engineered stock has ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies